Literature DB >> 27656507

Diagnostic Performance of Ultrasonography for Detection of Abruption and Its Clinical Correlation and Maternal and Foetal Outcome.

Gauri Raghunath Shinde1, Babita Prakash Vaswani2, R P Patange3, Manisha Manish Laddad4, Rajashree Babasaheb Bhosale5.   

Abstract

INTRODUCTION: Placental abruption complicates about 1% of singleton pregnancies and is an important cause of perinatal mortality and morbidity. Though sensitivity and reliability of ultrasound are poor for detecting or excluding placental abruption, because of the advances in ultrasound resolution, imaging and interpretation, sensitivity of ultrasound is better than what was reported previously. AIM: To determine the diagnostic performance of Ultrasonography (USG) for the detection of placental abruption and whether sonographic results correlate with maternal and foetal management and outcome.
MATERIALS AND METHODS: Thirty patients with clinical diagnosis of placental abruption were studied in the Obstetrics and Gynaecology Department of Krishna Institute of Medical Sciences, over a period of 6 months. These patients underwent ultrasonography for confirmation. Obstetric and neonatal outcome and sonographic results were compared and reviewed. Sonographic sensitivity and specificity and positive and negative predictive values were calculated.
RESULTS: Incidence of abruption in present study was 1.56% (28 patients out of 1786 total deliveries). Sensitivity of ultrasonography in the diagnosis of abruption was 57% (CI 37.15%-75.57%) while its specificity was 100% (CI 15.81%-100%) with a positive predictive value of 100% (CI 79.42%-100%) and a 14% (CI 1.78% - 42.83%) negative predictive value. An 87.5% of patients(14 out of 16) with a positive USG finding of abruption had Intrauterine foetal Death (IUD)/still birth while 91.6% of patients (11 out of 12) with negative USG findings of abruption gave birth to babies who required NICU admission.
CONCLUSION: Sonography is not sensitive for the detection of placental abruption but it is highly specific. Positive sonographic findings are associated with increased maternal morbidity, require more aggressive obstetric management and it is associated with worse perinatal outcome. In case of a negative USG finding, but a strong clinical suspicion of abruption if obstetric intervention is made in due time, foetal as well as maternal outcome are better. Foetal outcome also depends on gestational age. Preterm patients with positive USG and intrapartum findings of abruption have worse foetal outcome compared to full-term patients with abruption.

Entities:  

Keywords:  Antepartum haemorrhage; USG in antepartum haemorrhage

Year:  2016        PMID: 27656507      PMCID: PMC5028521          DOI: 10.7860/JCDR/2016/19247.8288

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  3 in total

Review 1.  Sonography of obstetric and gynecologic emergencies: Part II, Gynecologic emergencies.

Authors:  Y Kaakaji; H V Nghiem; C Nodell; T C Winter
Journal:  AJR Am J Roentgenol       Date:  2000-03       Impact factor: 3.959

2.  Clinical utility of sonography in the diagnosis and treatment of placental abruption.

Authors:  Chris Glantz; Leslie Purnell
Journal:  J Ultrasound Med       Date:  2002-08       Impact factor: 2.153

Review 3.  Placental abruption.

Authors:  Yinka Oyelese; Cande V Ananth
Journal:  Obstet Gynecol       Date:  2006-10       Impact factor: 7.661

  3 in total
  1 in total

1.  Routine antenatal ultrasound in low- and middle-income countries: first look - a cluster randomised trial.

Authors:  R L Goldenberg; R O Nathan; D Swanson; S Saleem; W Mirza; F Esamai; D Muyodi; A L Garces; L Figueroa; E Chomba; M Chiwala; M Mwenechanya; A Tshefu; A Lokangako; V L Bolamba; J L Moore; H Franklin; J Swanson; E A Liechty; C L Bose; N F Krebs; K Michael Hambidge; W A Carlo; N Kanaiza; F Naqvi; I S Pineda; W López-Gomez; D Hamsumonde; M S Harrison; M Koso-Thomas; M Miodovnik; D D Wallace; E M McClure
Journal:  BJOG       Date:  2018-06-15       Impact factor: 6.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.